JP2021504421A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504421A5 JP2021504421A5 JP2020529538A JP2020529538A JP2021504421A5 JP 2021504421 A5 JP2021504421 A5 JP 2021504421A5 JP 2020529538 A JP2020529538 A JP 2020529538A JP 2020529538 A JP2020529538 A JP 2020529538A JP 2021504421 A5 JP2021504421 A5 JP 2021504421A5
- Authority
- JP
- Japan
- Prior art keywords
- synthetic composition
- hmo
- gluten
- wheat
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 32
- 108010068370 Glutens Proteins 0.000 claims 15
- 235000021312 gluten Nutrition 0.000 claims 15
- 241000209140 Triticum Species 0.000 claims 14
- 235000021307 Triticum Nutrition 0.000 claims 14
- 206010020751 Hypersensitivity Diseases 0.000 claims 10
- 208000026935 allergic disease Diseases 0.000 claims 10
- 230000009610 hypersensitivity Effects 0.000 claims 10
- 241000282412 Homo Species 0.000 claims 8
- 229920001542 oligosaccharide Polymers 0.000 claims 8
- 150000002482 oligosaccharides Chemical class 0.000 claims 8
- 235000020256 human milk Nutrition 0.000 claims 7
- 210000004251 human milk Anatomy 0.000 claims 7
- IEQCXFNWPAHHQR-YKLSGRGUSA-N beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O IEQCXFNWPAHHQR-YKLSGRGUSA-N 0.000 claims 6
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 claims 6
- 230000007935 neutral effect Effects 0.000 claims 4
- 230000001939 inductive effect Effects 0.000 claims 3
- 230000009863 secondary prevention Effects 0.000 claims 3
- FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 claims 2
- 235000005911 diet Nutrition 0.000 claims 2
- 230000000378 dietary effect Effects 0.000 claims 2
- FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 claims 2
- 235000013339 cereals Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201700680 | 2017-11-30 | ||
| DKPA201700680 | 2017-11-30 | ||
| PCT/IB2018/059497 WO2019106618A1 (en) | 2017-11-30 | 2018-11-30 | Mixture of hmos for treating wheat sensitivity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021504421A JP2021504421A (ja) | 2021-02-15 |
| JP2021504421A5 true JP2021504421A5 (https=) | 2022-01-06 |
| JP7327724B2 JP7327724B2 (ja) | 2023-08-16 |
Family
ID=66664807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020529538A Active JP7327724B2 (ja) | 2017-11-30 | 2018-11-30 | 小麦過敏症を処置するためのhmoの混合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11452736B2 (https=) |
| EP (1) | EP3716984B1 (https=) |
| JP (1) | JP7327724B2 (https=) |
| KR (2) | KR20250058077A (https=) |
| CN (1) | CN111698994A (https=) |
| ES (1) | ES2987964T3 (https=) |
| WO (1) | WO2019106618A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3782480A4 (en) | 2018-03-29 | 2022-01-12 | Morinaga Milk Industry Co., Ltd. | NUTRITIONAL COMPOSITION, FOOD/DRINK COMPOSITION USING A NUTRITIONAL COMPOSITION AND MODIFIED MILK POWDER USING A NUTRITIONAL COMPOSITION |
| CN113194960A (zh) * | 2018-12-19 | 2021-07-30 | 格礼卡姆股份公司 | 用于治疗使用低fodmap饮食的人的组合物和方法 |
| KR20220017988A (ko) * | 2019-06-05 | 2022-02-14 | 글리콤 에이/에스 | 비-셀리악 밀 및/또는 글루텐 민감성을 앓고 있는 환자에서 증상 치료에 사용하기 위한 모유 올리고사카라이드 |
| JP2022132724A (ja) * | 2021-03-01 | 2022-09-13 | 国立研究開発法人農業・食品産業技術総合研究機構 | 免疫グロブリンa分泌促進剤 |
| WO2022218960A1 (en) * | 2021-04-13 | 2022-10-20 | Frieslandcampina Nederland B.V. | Nutritional composition for stimulationg bifidobacteria |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2796082B1 (fr) | 1999-07-07 | 2003-06-27 | Centre Nat Rech Scient | Procede de production d'oligosaccharides |
| WO2007101862A1 (en) | 2006-03-09 | 2007-09-13 | Centre National De La Recherche Scientifique (Cnrs) | Method of producing sialylated oligosaccharides |
| EP2405524B1 (en) | 2009-03-05 | 2015-10-07 | Nissan Motor Co., Ltd. | Bipolar secondary cell and method for producing the same |
| CN102459294A (zh) | 2009-04-07 | 2012-05-16 | 格礼卡姆股份公司 | 2’-o-岩藻糖基乳糖的合成 |
| ES2651067T3 (es) * | 2009-07-06 | 2018-01-24 | Children's Hospital Medical Center | Inhibición de la inflamación con oligosacáridos de la leche |
| EP3241836B1 (en) | 2010-02-19 | 2024-10-30 | Glycom A/S | Polymorph of a tetrasaccharide containing nacetyl-lactosamine |
| WO2011100979A1 (en) | 2010-02-19 | 2011-08-25 | Glycom A/S | Production of 6'-o-sialyllactose and intermediates |
| AU2011278236A1 (en) | 2010-07-16 | 2013-02-07 | Glycom A/S | Derivatization of oligosaccharides |
| MY191538A (en) * | 2010-12-31 | 2022-06-30 | Abbott Lab | Human milk oligosaccharides to promote growth of beneficial bacteria |
| CA2822219C (en) * | 2010-12-31 | 2020-12-29 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
| US20120171166A1 (en) * | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota |
| US20140187474A1 (en) * | 2011-02-16 | 2014-07-03 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic use of mucin glycans |
| WO2012113404A1 (en) | 2011-02-21 | 2012-08-30 | Glycom A/S | Novel glycosyl phosphites |
| CN103443113A (zh) | 2011-03-18 | 2013-12-11 | 格力康公司 | 新型含岩藻糖的糖类衍生物的合成 |
| WO2012155916A1 (en) | 2011-05-13 | 2012-11-22 | Glycom A/S | Manufacture of lacto-n-tetraose |
| CN103562401A (zh) | 2011-05-13 | 2014-02-05 | 格力康公司 | 产生人乳寡糖(hmo)或其前体的方法 |
| CN103562214B9 (zh) | 2011-05-13 | 2016-12-14 | 格力康公司 | 人乳寡糖(hmo)或其前体的多样化 |
| NL2007268C2 (en) | 2011-08-16 | 2013-02-19 | Friesland Brands Bv | Nutritional compositions comprising human milk oligosaccharides and uses thereof. |
| EP2760875A4 (en) | 2011-09-30 | 2015-08-26 | Glycom As | SYNTHESIS OF HMO NUCLEAR STRUCTURES |
| WO2013091660A1 (en) | 2011-12-23 | 2013-06-27 | Glycom A/S | A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof |
| WO2013139344A1 (en) | 2012-03-20 | 2013-09-26 | Glycom A/S | Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof |
| CA2893217C (en) * | 2012-12-18 | 2017-11-28 | Abbott Laboratories | Human milk oligosaccharides to ameliorate symptoms of stress |
| EP2935300B1 (en) * | 2012-12-18 | 2025-01-22 | Glycom A/S | Novel polymorphs of lnnt |
| US20160120915A1 (en) * | 2013-06-10 | 2016-05-05 | New York University | Methods for manipulating immune responses by altering microbiota |
| AU2014350419B2 (en) * | 2013-11-15 | 2019-10-24 | Société des Produits Nestlé S.A. | Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section |
| ES2870425T3 (es) * | 2014-10-29 | 2021-10-27 | Biogaia Ab | Uso de L. reuteri para la prevención o el tratamiento de la disbiosis de microbiota en la vida temprana |
| EP3212197A4 (en) * | 2014-10-29 | 2018-07-11 | Glycom A/S | Synthetic composition and method for treating irritable bowel syndrome |
| EP3229812A4 (en) | 2014-12-08 | 2018-10-03 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| US20170000830A1 (en) * | 2015-07-01 | 2017-01-05 | Rakesh Saini | Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof |
| ES2886951T3 (es) | 2015-09-14 | 2021-12-21 | Glycom As | Composición para su uso en la modulación de la microbiota |
| DK3452050T3 (da) | 2016-05-05 | 2023-02-20 | Glycom As | Composition comprising hmos for the treatment of noninfectious diarrhoea |
| JP2020513014A (ja) * | 2017-04-07 | 2020-04-30 | チルドレンズ ホスピタル メディカル センター | 2’−フコシルラクトース化合物による炎症性腸疾患の治療 |
| US11602545B2 (en) * | 2017-12-05 | 2023-03-14 | Glycom A/S | Human milk oligosaccharides for treating migraine |
| WO2019123316A1 (en) | 2017-12-22 | 2019-06-27 | Glycom A/S | Composition comprising hmos for preventing or reducing nociception |
-
2018
- 2018-11-30 EP EP18883241.4A patent/EP3716984B1/en active Active
- 2018-11-30 KR KR1020257013527A patent/KR20250058077A/ko active Pending
- 2018-11-30 ES ES18883241T patent/ES2987964T3/es active Active
- 2018-11-30 JP JP2020529538A patent/JP7327724B2/ja active Active
- 2018-11-30 KR KR1020207018743A patent/KR20200096263A/ko not_active Ceased
- 2018-11-30 CN CN201880088048.9A patent/CN111698994A/zh active Pending
- 2018-11-30 US US16/768,333 patent/US11452736B2/en active Active
- 2018-11-30 WO PCT/IB2018/059497 patent/WO2019106618A1/en not_active Ceased
-
2022
- 2022-09-21 US US17/934,123 patent/US11986487B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504421A5 (https=) | ||
| JP2021504420A5 (https=) | ||
| Appanna | Dysbiosis, probiotics, and prebiotics: in diseases and health | |
| JP2017533915A5 (https=) | ||
| JP2009535419A5 (https=) | ||
| RU2005121665A (ru) | Пребиотические композиции | |
| Ramos-Gallardo | Chronic wounds in burn injury: a case report on importance of biofilms | |
| TWI640313B (zh) | 戈氏副擬桿菌用於抑制肥胖之用途 | |
| CN105030841A (zh) | Akkermansia muciniphila BAA-835菌株的应用 | |
| JP2020178685A (ja) | 腸管障害の予防、治療又は抑制用組成物 | |
| CN103976359B (zh) | 食品营养强化组合物及其应用、保健食品及其制备方法 | |
| CN109419817B (zh) | 戈氏副拟杆菌用于降低胰岛素抗性及提升葡萄糖耐受性的用途 | |
| Fatima et al. | Nutritional supplements and their use in the treatment of malnutrition in developing countries | |
| Green et al. | Chemotherapy in the geriatric population. | |
| CN105380031A (zh) | 一种保健食品及其制备方法 | |
| Waitzberg | Efficacy of Nutritional Support: Evidence-Based Nutrition | |
| Hansen | The clinical diagnosis of acute rhinosinusitis and its therapeutic consequences | |
| Prousky | The use of Niacinamide and Solanaceae (Nightshade) Elimination in the Treatment of Osteoarthritis. | |
| CN110101757A (zh) | 一种适用于痛风及高尿酸人群的营养组合物 | |
| RU2593584C1 (ru) | Средство для восстановления кишечного микробиоценоза при дисбиозах | |
| Wang | 22 Human Clinical Trial for Nutraceuticals and Functional Foods | |
| Gumble et al. | Examination of ghrita on various types of chronic diseases in pediatrics | |
| Gupta et al. | Traditional beliefs and practices among graduate mothers regarding various paediatric ailments | |
| CN106511447A (zh) | 一种细胞障碍修复营养补充方法及其药物配方 | |
| Marques et al. | Limited health literacy and its association with poor surgical outcomes under a colorectal enhanced recovery after surgery (ERAS) program |